1.Anti-HMGCR immune-mediated necrotizing myopathy: A case report.
Yuan Jin ZHANG ; Jing Yue MA ; Xiang Yi LIU ; Dan Feng ZHENG ; Ying Shuang ZHANG ; Xiao Gang LI ; Dong Sheng FAN
Journal of Peking University(Health Sciences) 2023;55(3):558-562
The patient was a 55-year-old man who was admitted to hospital with "progressive myalgia and weakness for 4 months, and exacerbated for 1 month". Four months ago, he presented with persistent shoulder girdle myalgia and elevated creatine kinase (CK) at routine physical examination, which fluctuated from 1 271 to 2 963 U/L after discontinuation of statin treatment. Progressive myalgia and weakness worsened seriously to breath-holding and profuse sweating 1 month ago. The patient was post-operative for renal cancer, had previous diabetes mellitus and coronary artery disease medical history, had a stent implanted by percutaneous coronary intervention and was on long-term medication with aspirin, atorvastatin and metoprolol. Neurological examination showed pressure pain in the scapularis and pelvic girdle muscles, and V- grade muscle strength in the proximal extremities. Strongly positive of anti-HMGCR antibody was detected. Muscle magnetic resonance imaging (MRI) T2-weighted image and short time inversion recovery sequences (STIR) showed high signals in the right vastus lateralis and semimembranosus muscles. There was a small amount of myofibrillar degeneration and necrosis, CD4 positive inflammatory cells around the vessels and among myofibrils, MHC-Ⅰ infiltration, and multifocal lamellar deposition of C5b9 in non-necrotic myofibrils of the right quadriceps muscle pathological manifestation. According to the clinical manifestation, imageological change, increased CK, blood specific anti-HMGCR antibody and biopsy pathological immune-mediated evidence, the diagnosis of anti-HMGCR immune-mediated necrotizing myopathy was unequivocal. Methylprednisolone was administrated as 48 mg daily orally, and was reduced to medication discontinuation gradually. The patient's complaint of myalgia and breathlessness completely disappeared after 2 weeks, the weakness relief with no residual clinical symptoms 2 months later. Follow-up to date, there was no myalgia or weakness with slightly increasing CK rechecked. The case was a classical anti-HMGCR-IMNM without swallowing difficulties, joint symptoms, rash, lung symptoms, gastrointestinal symptoms, heart failure and Raynaud's phenomenon. The other clinical characters of the disease included CK as mean levels >10 times of upper limit of normal, active myogenic damage in electromyography, predominant edema and steatosis of gluteus and external rotator groups in T2WI and/or STIR at advanced disease phase except axial muscles. The symptoms may occasionally improve with discontinuation of statins, but glucocorticoids are usually required, and other treatments include a variety of immunosuppressive therapies such as methotrexate, rituximab and intravenous gammaglobulin.
Male
;
Humans
;
Middle Aged
;
Autoantibodies
;
Myositis/diagnosis*
;
Autoimmune Diseases
;
Muscle, Skeletal/pathology*
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*
;
Necrosis/pathology*
;
Muscular Diseases/drug therapy*
2.Application and Effectiveness of Chinese Medicine in Regulating Immune Checkpoint Pathways.
Luo-Jie XIONG ; Yue-Feng TIAN ; Chun-Tao ZHAI ; Wei LI
Chinese journal of integrative medicine 2023;29(11):1045-1056
Immunotherapy targeting immune checkpoint molecules has emerged as a key approach in cancer treatment, representing the forefront of antitumor research. However, studies on immune checkpoint molecules have mainly focused on targeted therapies. Chinese medicine (CM) research as a complementary medicine has revealed that immune checkpoint molecules also undergo disease-specific changes in the context of autoimmune diseases. This review article presents a comprehensive analysis of CM studies on immune checkpoint molecules in the last 5 years, with a focus on their role in different diseases and treatment modalities. CM research predominantly utilizes oral administration of herbal plant extracts or acupuncture techniques, which stimulate the immune system by activating specific acupoints through temperature and needling. In this study, we analyzed the modulation and mechanisms of immune checkpoint molecules associated with different coinhibitory and costimulatory molecules, and reviewed the immune functions of related molecules and CM studies in treating autoimmune diseases and tumors. By summarizing the characteristics and research value of CM in regulating immune checkpoint molecules, this review aims to provide a useful reference for future studies in this field.
Humans
;
Medicine, Chinese Traditional/methods*
;
Immune Checkpoint Proteins
;
Acupuncture Therapy/methods*
;
Neoplasms/pathology*
;
Autoimmune Diseases
3.IgG4-related diseases of retroperitoneum in urinary and male reproductive system: a clinicopathological analysis of eleven cases.
Wen Jing SU ; Ning CHANG ; Hui Ying HE
Chinese Journal of Pathology 2022;51(10):970-975
Objective: To analyze the clinicopathological features of IgG4-related diseases (RD) of retroperitoneum and the urinary and male reproductive system (IgG4-RUMR). Methods: A total of 11 IgG4-RUMR cases from January 2013 to March 2021 were retrospectively collected at Peking University Third Hospital and Shandong Provincial Hospital affiliated to Shandong First Medical University. The clinicopathologic features, laboratory and imaging findings were analyzed and scored according to the 2019 ACR/EULAR classification criteria for IgG4-RD. Results: The 11 patients (male:female is 9∶2; mean age 59 years, range from 44 to 83 years) were initially admitted to the Deparment of Urology/Kidney Transplantation (10 cases) and the Department of Oncology (1 case). All patients had urogenital disorders or imaging abnormalities. Three of the 11 patients had a history of IgG4-RD such as lacrimal gland engorgement, salivary gland engorgement and IgG4-associated pancreatitis. Abnormal retroperitoneal soft tissue and hydronephrosis were found in eight cases, while epididymal and spermatic cord masses were found in one case, simple renal mass in one case, and"benign prostatic hyperplasia"in one case. In the 10 patients tested for serum IgG4, the serum IgG4 level was 0.8-14.4 g/L. Histologically, all cases showed significant lymphoplasmacytic infiltration and storiform fibrosis, and some were accompanied by obliterative phlebitis. The number of IgG4 positive plasma cells was 12-155 per high-power field, and the IgG4/IgG ratio was 15%-77%. According to the 2019 ACR/EULAR IgG4-RD classification standard 11 cases scored 20-48 points, all of which met the diagnostic criteria of IgG4-RUMR. Therapeutically, the patient with a simple renal mass underwent partial nephrectomy. The patient with prostate lesion underwent transurethral resection of prostate and was initially diagnosed as nonspecific chronic prostatitis. Later, the patient was admitted again because of salivary gland swelling, and the pathologic diagnosis was amended. The patient with epididymal and spermatic cord masses participated in a clinical trial about retroperitoneal fibrosis. The remaining eight patients received symptomatic treatment such as adhesiolysis and stent placement. All the patients were subsequently treated with glucocorticoid/immunosuppressant and symptoms relieved. Conclusions: IgG4-RUMR is uncommon. In clinical practice, information from clinical, serologic, radiologic and pathologic evaluations must be integrated. IgG4-RUMR should be considered in the differential diagnosis of urinary and male reproductive diseases. The 2019 ACR/EULAR classification criteria for IgG4-RD, while relatively complex, are objective and practical in the diagnosis of IgG4-RUMR.
Adult
;
Aged
;
Aged, 80 and over
;
Autoimmune Diseases/pathology*
;
Female
;
Glucocorticoids
;
Humans
;
Immunoglobulin G
;
Immunoglobulin G4-Related Disease/pathology*
;
Immunosuppressive Agents
;
Male
;
Middle Aged
;
Prostate/pathology*
;
Retrospective Studies
;
Transurethral Resection of Prostate
4.Liver involvement in endocrine diseases.
Qian Yi WANG ; Xiao Juan OU ; Ji Dong JIA
Chinese Journal of Hepatology 2022;30(4):352-356
As a secondary endocrine organ, the liver is closely related to the endocrine system. Liver involvement is not uncommon in endocrine diseases, such as hyper/hypothyroidism, diabetes, dysfunction of adrenal and gonadal. It can be manifested in a variety of forms, including hepatocyte injury (elevated transaminase), bile duct injury (cholestasis), hepatocyte steatosis, vascular injury and liver tumor. Direct and indirect liver injury caused by abnormal hormone levels and side effects of drugs for the treatment of endocrine diseases are common pathogenesis. In addition, endocrine diseases can be concomitant with liver diseases, such as autoimmune thyroiditis and autoimmune hepatitis. Systemic diseases can also involve the endocrine system and liver at the same time, such as systemic lupus erythematosus and IgG4 related diseases. For patients with unexplained liver injury, endocrine system diseases should be considered as the differential diagnosis.
Cholestasis/pathology*
;
Endocrine System Diseases/pathology*
;
Hepatitis, Autoimmune/pathology*
;
Humans
;
Liver/pathology*
;
Liver Diseases/pathology*
5.Advances in gut microbiomes and immunology of IgG4-related hepatobiliary and pancreatic diseases.
Chinese Journal of Hepatology 2022;30(4):452-456
IgG4-related disease (IgG4-RD) is an immune-mediated condition associated with chronic fibroinflammatory lesions that can affect nearly any organ. IgG4-related hepatobiliary and pancreatic diseases are IgG4-RD involving the hepatobiliary and pancreatic system, which is characterized with elevated serum IgG4 concentrations, large numbers of IgG4 positive lymphoplasma cells infiltration in affected organs, storiform fibrosis, and imaging changes of organ morphology. Due to the lack of reliable biomarkers, histopathology is still an important basis for diagnosis. The pathogenesis of IgG4-related hepatobiliary and pancreatic diseases has not been clarified. This review focuses on the recent advances in intestinal microecology-immunology, host genetics-immunity and recurrence monitoring of IgG4-related hepatobiliary and pancreatic diseases.
Autoimmune Diseases/diagnosis*
;
Gastrointestinal Microbiome
;
Humans
;
Immunoglobulin G
;
Immunoglobulin G4-Related Disease/pathology*
;
Pancreatic Diseases
6.Aging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice.
He LI ; Lei ZHU ; Rong WANG ; Lihui XIE ; Jie REN ; Shuai MA ; Weiqi ZHANG ; Xiuxing LIU ; Zhaohao HUANG ; Binyao CHEN ; Zhaohuai LI ; Huyi FENG ; Guang-Hui LIU ; Si WANG ; Jing QU ; Wenru SU
Protein & Cell 2022;13(6):422-445
Aging-induced changes in the immune system are associated with a higher incidence of infection and vaccination failure. Lymph nodes, which filter the lymph to identify and fight infections, play a central role in this process. However, careful characterization of the impact of aging on lymph nodes and associated autoimmune diseases is lacking. We combined single-cell RNA sequencing (scRNA-seq) with flow cytometry to delineate the immune cell atlas of cervical draining lymph nodes (CDLNs) of both young and old mice with or without experimental autoimmune uveitis (EAU). We found extensive and complicated changes in the cellular constituents of CDLNs during aging. When confronted with autoimmune challenges, old mice developed milder EAU compared to young mice. Within this EAU process, we highlighted that the pathogenicity of T helper 17 cells (Th17) was dampened, as shown by reduced GM-CSF secretion in old mice. The mitigated secretion of GM-CSF contributed to alleviation of IL-23 secretion by antigen-presenting cells (APCs) and may, in turn, weaken APCs' effects on facilitating the pathogenicity of Th17 cells. Meanwhile, our study further unveiled that aging downregulated GM-CSF secretion through reducing both the transcript and protein levels of IL-23R in Th17 cells from CDLNs. Overall, aging altered immune cell responses, especially through toning down Th17 cells, counteracting EAU challenge in old mice.
Aging
;
Animals
;
Autoimmune Diseases
;
Disease Models, Animal
;
Granulocyte-Macrophage Colony-Stimulating Factor/metabolism*
;
Mice
;
Mice, Inbred C57BL
;
Th17 Cells/metabolism*
;
Uveitis/pathology*
;
Virulence
7.Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord.
Diego MORENO ; Cristian M SOBARZO ; Livia LUSTIG ; Marcelo G RODRÍGUEZ PEÑA ; Vanesa Anabella GUAZZONE
Asian Journal of Andrology 2020;22(1):112-117
The aim of this work was to study effects of ketotifen fumarate (KF) on prevention of tissue damage in testes of rats with experimental autoimmune orchitis (EAO) and on the contralateral testis in a model of prolonged testicular cord torsion (TCT). Rats with EAO or TCT were injected intraperitoneally once daily with KF or saline solution (vehicle group). Incidence and severity of testicular damage were evaluated by histopathology using an EAO score or a Johnsen score. Mast cells (MC) were identified by histochemistry and quantified. In EAO model, KF significantly reduced severity of histopathological testicular damage compared to rats in the vehicle group. KF also reduced the number of testicular MC compared to vehicle group. Similarly, in TCT model, multifocal damage of the contralateral testis was observed 30 days after testicular torsion characterized by sloughing of the germinal epithelium, seminiferous tubule atrophy, and interstitial edema. Focal signs of inflammation and fibrosis of seminiferous tubular walls were also observed. In contrast, sections of contralateral testis of rats injected with KF and killed 30 days after surgery showed normal histological features. A significant decrease in the number of MC was observed in rats treated with KF compared to untreated animals. In conclusion, we demonstrated that treatment with KF reduced testicular inflammatory process and MC infiltrates in both EAO and TCT models. The results suggest a promising treatment for infertile male patients with testicular pathologies associated with inflammation and germ cell loss.
Animals
;
Autoimmune Diseases/pathology*
;
Cell Count
;
Epididymis/pathology*
;
Epididymitis/pathology*
;
Histamine H1 Antagonists/pharmacology*
;
Hypersensitivity, Delayed
;
Immunity, Cellular/drug effects*
;
Ketotifen/pharmacology*
;
Male
;
Mast Cells/pathology*
;
Orchitis/pathology*
;
Rats
;
Severity of Illness Index
;
Spermatic Cord Torsion/pathology*
;
Testis/pathology*
;
Vaccination
8.Age-related Autoimmune Changes in Lacrimal Glands
Rodrigo G DE SOUZA ; Cintia S DE PAIVA ; Milton R ALVES
Immune Network 2019;19(1):e3-
Aging is a complex process associated with dysregulation of the immune system and low levels of inflammation, often associated with the onset of many pathologies. The lacrimal gland (LG) plays a vital role in the maintenance of ocular physiology and changes related to aging directly affect eye diseases. The dysregulation of the immune system in aging leads to quantitative and qualitative changes in antibodies and cytokines. While there is a gradual decline of the immune system, there is an increase in autoimmunity, with a reciprocal pathway between low levels of inflammation and aging mechanisms. Elderly C57BL/6J mice spontaneously show LGs infiltration that is characterized by Th1 but not Th17 cells. The aging of the LG is related to functional alterations, reduced innervation and decreased secretory activities. Lymphocytic infiltration, destruction, and atrophy of glandular parenchyma, ductal dilatation, and secretion of inflammatory mediators modify the volume and composition of tears. Oxidative stress, the capacity to metabolize and eliminate toxic substances decreased in aging, is also associated with the reduction of LG functionality and the pathogenesis of autoimmune diseases. Although further studies are required for a better understanding of autoimmunity and aging of the LG, we described anatomic and immunology aspects that have been described so far.
Aged
;
Aging
;
Allergy and Immunology
;
Animals
;
Antibodies
;
Atrophy
;
Autoimmune Diseases
;
Autoimmunity
;
Cytokines
;
Dilatation
;
Eye Diseases
;
Humans
;
Immune System
;
Inflammation
;
Lacrimal Apparatus
;
Mice
;
Ocular Physiological Phenomena
;
Oxidative Stress
;
Pathology
;
Tears
;
Th17 Cells
9.Critical effects of long non-coding RNA on fibrosis diseases
Yue ZHANG ; Gang LUO ; Yi ZHANG ; Mengjie ZHANG ; Jian ZHOU ; Weiwu GAO ; Xiuyun XUAN ; Xia YANG ; Di YANG ; Zhiqiang TIAN ; Bing NI ; Jun TANG
Experimental & Molecular Medicine 2018;50(1):e428-
The expression or dysfunction of long non-coding RNAs (lncRNAs) is closely related to various hereditary diseases, autoimmune diseases, metabolic diseases and tumors. LncRNAs were also recently recognized as functional regulators of fibrosis, which is a secondary process in many of these diseases and a primary pathology in fibrosis diseases. We review the latest findings on lncRNAs in fibrosis diseases of the liver, myocardium, kidney, lung and peritoneum. We also discuss the potential of disease-related lncRNAs as therapeutic targets for the clinical treatment of human fibrosis diseases.
Autoimmune Diseases
;
Fibrosis
;
Genetic Diseases, Inborn
;
Humans
;
Kidney
;
Liver
;
Lung
;
Metabolic Diseases
;
Myocardium
;
Pathology
;
Peritoneum
;
RNA, Long Noncoding
10.NKT cells in liver diseases.
Shasha ZHU ; Huimin ZHANG ; Li BAI
Frontiers of Medicine 2018;12(3):249-261
Natural killer T cells are innate-like and tissue-resident lymphocytes, which recognize lipid antigens and are enriched in the liver. Natural killer T cells play important roles in infections, tumors, autoimmune diseases, and metabolic diseases. In this study, we summarize recent findings on biology of natural killer T cells and their roles in hepatitis B virus and hepatitis C virus infection, autoimmune liver diseases, alcoholic liver disease, nonalcoholic fatty liver disease, and hepatocellular carcinoma. Controversial results from previous studies are discussed, and indicate the dynamic alteration in the role of natural killer T cells during the progression of liver diseases, which might be caused by changes in natural killer T subsets, factors skewing cytokine responses, and intercellular crosstalk between natural killer T cells and CD1d-expressing cells or bystander cells.
Animals
;
Autoimmune Diseases
;
immunology
;
Humans
;
Liver
;
pathology
;
Liver Diseases
;
immunology
;
Natural Killer T-Cells
;
immunology

Result Analysis
Print
Save
E-mail